Application progress of ROX index in evaluating the efficacy of pediatric high-flow nasal cannula oxygen therapy
10.3760/cma.j.cn121430-20240326-00289
- VernacularTitle:ROX指数在评估儿科经鼻高流量氧疗效果中的应用进展
- Author:
Shaodong ZHAO
1
;
Hongjun MIAO
Author Information
1. 南京医科大学附属儿童医院急/重症医学科，江苏南京 210008
- Keywords:
ROX index;
High-flow nasal cannula oxygen therapy;
PaO 2/FiO 2;
Pediatric
- From:
Chinese Critical Care Medicine
2024;36(11):1230-1232
- CountryChina
- Language:Chinese
-
Abstract:
Respiratory support is one of the key technologies for treating pediatric respiratory diseases. High-flow nasal cannula oxygen therapy (HFNC) represents a novel method of assisted respiratory support. The commonly used indicator for assessing HFNC efficacy in clinical practice is oxygenation index (PaO 2/FiO 2). However, this parameter has several limitations when evaluating the efficacy of HFNC in pediatrics. The ROX index, introduced in recent years, offers a more sensitive and specific assessment tool. This article reviews the application of the ROX index in assessing the efficacy of HFNC for pediatric respiratory failure, aiming to provide a more accurate assessment method.
